Evidence map›Paper›PMID 32158189›Full record

ArticleDrug design, development and therapy2020

Cardioprotective Effect of Monoammonium Glycyrrhizinate Injection Against Myocardial Ischemic Injury in vivo and in vitro: Involvement of Inhibiting Oxidative Stress and Regulating Ca

Zhifeng Zhao, Miaomiao Liu, Yuanyuan Zhang, Yingran Liang, Donglai Ma, Hongfang Wang, Zhihong Ma, Shengjiang Guan, Zhonglin Wu, Xi Chu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Effects and pharmacological mechanism of Zhigancao Decoction on electrical and structural remodeling of the atrium of rabbits induced by rapid atrial pacing.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023
    Article
  7. Article
  8. Article
  9. The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions.Phytomedicine plus : international journal of phytotherapy and phytopharmacology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Zhifeng Zhao *School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Miaomiao Liu *School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Yuanyuan ZhangSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Yingran LiangSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Donglai MaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Hongfang WangSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Zhihong MaSchool of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Shengjiang GuanSchool of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Zhonglin WuThe Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, People's Republic of China.
Xi ChuThe Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, People's Republic of China.
Yue LinSchool of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Li ChuSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.
Hebei University of Chinese Medicine · CNFourth Hospital of Hebei Medical University · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMonoammonium glycyrrhizinate (MAG) is an aglycone of glycyrrhizin that is found in licorice and is often used clinically as an injection to treat liver diseases. However, the effect of MAG injection on cardiac function and its possible cellular mechanisms remain unclear. We explored the protective effects of MAG against myocardial ischemic injury (MII) induced by isoproterenol (ISO), as well as the cellular mechanisms via molecular biology techniques and patch-clamp recording.

methodsA rat model of myocardial ischemia injury was induced by administering ISO (85 mg/kg) subcutaneously for 2 consecutive days. ECG, cardiac functional parameters, CK and LDH levels, SOD and GSH activities, MDA concentration, histological myocardium inspection, mitochondria ultrastructure changes, intracellular calcium concentrations were observed. Influences of MAG on I

resultsMAG reduced damage, improved cardiac morphology, inhibited oxidative stress, decreased the generation of reactive oxygen species, and decreased intracellular Ca

conclusionThe findings indicate that MAG injection exerts a protective influence on ISO-induced MII by inhibiting oxidative stress and regulating Ca

Indexed as

AnimalsAnti-Inflammatory AgentsCalciumCalcium Channels, L-TypeCardiotonic AgentsElectrocardiographyGlycyrrhizic AcidHomeostasisMaleMolecular ConformationMyocardial Reperfusion InjuryOxidative StressRatsRats, Sprague-DawleyAnti-Inflammatory AgentsCalciumCalcium Channels, L-TypeCardiotonic AgentsGlycyrrhizic Acidcalcium concentrationcalcium influxcardiopretectionisoproterenolreactive oxygen species

Identifiers

PMID32158189
PMCPMC6986180
OpenAlexW3002282807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.